|
|
|
Dr Julia Morizzi
Bioanalytical leader, Centre for Drug Candidate Optimisation
BSc RMIT University
PhD RMIT University
Telephone: +61 3 9903 9059
Fax: +61 3 9903 9052
Email: julia.morizzi@pharm.monash.edu.au
Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences
- Drug discovery and lead optimisation
- Pre-clinical development of new drug candidates
Representative publications
-
Zhou L, Alker A, Ruf A, Wang X, Chiu FCK, Morizzi J, et.al. Characterization of the Two Major CYP450 Metabolites of Ozonide (1,2,4-trioxolane) OZ277. Bioorg Med Chem Lett. 2008; 18:1555-1558.
-
Morizzi J, Hobday M, Rix C. Gallium(III) Organophosphonate Adducts with Bidentate Amines 2,2’-Bipyridyl and 1,10-Phenanthroline. Inorganica Chimica Acta. 2001; 320:67-74
-
Morizzi J, Hobday M, Rix C. Some Bidentate Amine Adducts of Indium(III) Organophosphonates. Journal of Materials Chemistry. 2001; 11:1-6.
-
Morizzi J, Hobday M, Rix C. Synthesis and Characterisation of a Series of Lamellar Gallium and Indium Phosphonates and Related Compounds. Journal of Materials Chemistr. 2000;10:1693-1697.
-
Morizzi J, Hobday M, Rix C. Synthesis and Characterisation of Some Lamellar Indium(III) Organophosphonates. Journal of Materials Chemistry. 1999; 9:863-864.
|